QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
New study published on ICD-11 requirements
In Quantify’s latest publication co-authored by Christoph Abé, PhD, the research group conducted a field trial focused on the ICD-11 chapter on mental disorders which contains new diagnoses for impulse control disorders.
Using a vignette-based methodology, this field study examined the ability of more than 1,000 mental health professionals across the World Health Organization‘s Global Clinical Practice Network to apply the new […]
Kicking off 2024 with a bang!💥
This Monday the Quantify Research teams across the globe got together for our annual January Kick-Off.
We celebrated our successes from last year whilst looking ahead at a very exciting 2024. We wrapped up the day with a burning and planting ceremony before our teams headed out to a few different locations for the evening.
We are looking forward to keeping all of you updated […]
Exploring Observational Studies in Swedish Regional Data: Seminar by Quantify’s Emilie Toresson Grip at Karolinska Institutet, Jan 24th
This Wednesday January 24th, Quantify’s Emilie Toresson Grip, Head of RWE and Analytics, will hold a presentation on this topic at the Centre for Bioinformatics and Biostatistics (CBB) at Karolinska Institutet.
Emilie will present a case example of an observational study that extracted and linked administrative data with information from the Intelligence database containing data from electronic health care records (EHR) in the Stockholm Region.
This seminar […]
New cost-effectiveness evidence on nirmatrelvir/ritonavir in the progression of COVID-19
Not only can SARS-CoV-2 infection result in immediate respiratory symptoms, but it can also lead to post-acute COVID-19 syndrome (PACS), lasting several months after recovery. At this year’s ISPOR in Copenhagen, Quantify Research’s own Martina Aldvén and Marcelina Kądziela, in collaboration with Pfizer, presented a poster on the cost-effectiveness of nirmatrelvir/ritonavir (NV/r) compared to no anti-viral treatment in Swedish […]